MDAP-2 [Q35R]

General Information


DRACP ID  DRACP04091

Peptide Name   MDAP-2 [Q35R]

Sequence  SRDSRPVQPRVQPPPPPPKQKPSIYDTPIRRPGGRKTMYA

Sequence Length  40

UniProt ID  A0A088N522 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C201H328N64O55S

Absent amino acids  CEFHLNW

Common amino acids  P

Mass  524903

Pl  11.92

Basic residues  9

Acidic residues  2

Hydrophobic residues  5

Net charge  7

Boman Index  -13189

Hydrophobicity  -149.75

Aliphatic Index  36.5

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  2980

Absorbance 280nm  76.41

Polar residues  9

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Design and Characterization of a Novel Hybrid Antimicrobial Peptide OM19R Based on Oncocin and MDAP-2

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  16977

DRACP is developed by Dr.Zheng's team.